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Abstract
Background: CALM1 gene encodes calmodulin (CaM), an important and ubiquitous eukaryotic
Ca2+-binding protein. Several studies have indicated that a deficient CaM function is likely to be
involved in the pathogenesis of osteoarthritis (OA). Using a convincing genome-wide association
study, a Japanese group has recently demonstrated a genetic association between the CALM1 core
promoter polymorphism (-16C/T transition SNP, rs12885713) and OA susceptibility. However,
the subsequent association studies failed to provide consistent results in OA patients of differently
selected populations. The present study is to evaluate the association of the -16C/T polymorphism
with knee OA in a Chinese Han population.
Methods: A case-control association study was conducted. The polymorphism was genotyped in
183 patients who had primary symptomatic knee OA with radiographic confirmation and in 210
matched controls. Allelic and genotypic frequencies were compared between patients and control
subjects.
Results: No significant difference was detected in genotype or allele distribution between knee
OA and control groups (all P > 0.05). The association was also negative even after stratification by
sex. Furthermore, no association between the -16C/T SNP genotype and the clinical variables age,
sex, BMI (body mass index) and K/L (Kellgren/Lawrence) score was observed in OA patients.
Conclusion: The present study suggests that the CALM1 core promoter polymorphism -16C/T
is not a risk factor for knee OA susceptibility in the Chinese Han population. Further studies are
needed to give a global view of this polymorphism in pathogenesis of OA.
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Background
Osteoarthritis (OA) is a common musculoskeletal disease
among the elderly, characterized by the degradation of
articular cartilage and formation of abnormal bone (oste-
ophyte). It is a multifactorial disorder in which aging,
genetic, hormonal and mechanical factors are all major
contributors to its onset and progression [1]. Results of
family-based and candidate gene studies have demon-
strated a clear genetic component, particularly for early-
onset OA [2-4]. The identification of candidate genes for
OA susceptibility has mainly focused on genes encoding
collagens (particularly for type II collagen), for other
structural proteins of the extracellular cartilage
matrix(ECM), the vitamin D and estrogen receptor genes,
and for bone and cartilage growth factors [5]. And it is
expected that some genes which regulate the formation,
degradation, and repair of articular cartilage and subchon-
dral bone metabolism may determine the occurrence of
osteoarthritis. However, the specific underlying genetic
factors and mechanisms in the development of osteoar-
thritis need to be further researched.
Calmodulin 1 gene (CALM1) encodes calmodulin (CaM),
a ubiquitous eukaryotic Ca2+-binding protein which regu-
lates many Ca2+-dependent cellular events by interacting
with a heterogeneous group of target proteins [6]. Several
studies have indicated that calmodulin probably plays a
crucial role in articular cartilage on at least three aspects:
regulating articular chondrogenesis [7], maintaining the
cartilage phenotype in response to mechanical stimuli in
mature chondrocytes [8,9] and modulating adhesion of
chondrocytes to extracellular matrix proteins during the
cartilage repairing process [10]. Consequently, a defi-
ciency of Ca2+-calmodulin signal may be involved in the
pathogenesis of OA.
Through a genome-wide association study, Mototani et al
[7] previously reported a functional single nucleotide pol-
ymorphism (SNP) (-16C/T rs12885713) in the core pro-
moter region of the CALM1  gene associated with a
markedly increased prevalence of hip OA in the Japanese
population. Subsequent functional analyses revealed that
the susceptibility -16T allele of this polymorphism
decreased CALM1 transcription both in vitro and in vivo.
In addition, higher levels of CALM1 expression in hip and
knee OA cartilage than in normal were also observed [7].
Together, these findings implicated the candidacy of
CALM1 as a susceptibility gene for OA. However, subse-
quent association studies [11,12] failed to provide con-
sistent results in OA patients of differently selected
populations. To clarify its global relevance, the associa-
tion needs to be confirmed by independent studies in dif-
ferent ethnic groups. The objective of this study is to assess
the genetic association of the -16C/T polymorphism in
CALM1 with knee OA in a Chinese Han population.
Methods
Subjects
A total of 183 patients with primary knee OA (124 women
and 59 men) were recruited consecutively at the Center of
Diagnosis and Treatment for Joint Disease, Drum Tower
Hospital, affiliated to the Medical School of Nanjing Uni-
versity and 210 healthy control subjects (142 women and
68 men) were recruited at the Center of Physical Examina-
tion. All subjects included in the study were Han Chinese
living in or around Nanjing. The study was approved by
the ethics review committee of the Medical School of Nan-
jing University and written informed consent was
obtained from all participants. The ascertainment criteria
for both OA patients and control subjects were according
to the previously published study by Jiang et al [13]. In the
study, other etiologies causing knee diseases such as
inflammatory arthritis (rheumatoid, polyarthritic, or
autoimmune disease), posttraumatic or post-septic arthri-
tis, skeletal dysplasia or developmental dysplasia were
excluded. Radiographic OA was assessed using the Kell-
gren/Lawrence (K/L) grading system [14]. Only patients
with K/L grades of 2 or higher were included. All the con-
trol never had any signs or symptoms of arthritis or joint
diseases (pain, swelling, tenderness, or restriction of
movement)
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using the Chelex-100 method [15] or from buccal
swabs using the DNA IQ System (Promega, Madison, WI)
according to the manufacturer's instructions. PCR ampli-
fications were performed for the -16C/T SNP using for-
ward primer 5'GCG GGA GGC CTG GCG AAC3' and
reverse primer 5'CAC TGC CGG AGC GCG AGT GT3'. The
italic and boldfaced nucleotide in the reverse primer is a
G as opposed to the C that exists in the CALM1 sequence
in order to create a APAL‡T restriction enzyme site in the
T-allele of the SNP which is absent in the C-allele. The
amplification solution system was supplemented with 5%
dimethyl sulfoxide (DMSO) [11]. Amplification was car-
ried out as follows: 31 cycles consisting of 1 min of dena-
turation at 94°C, 1 min of annealing at 62°C and 1 min
of extension at 72°C with an initial denaturation step of
2 min at 96°C and a final extension of 15 min at 72°C.
The 148 bp PCR product was then digested with APALI
(New England Biolabs, Hitchin, UK). After that, a T-allele
was digested into two fragments, of 125 bp and 23 bp,
whilst a C-allele remained uncut. Restriction fragments
were separated by 3% agarose gel electrophoresis and
ethidium bromide staining. To verify the results of the
original assay, randomly selected 10% samples were
amplified using a second pair of sequencing primers: for-BMC Medical Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2350/9/91
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ward 5'CTT CCC CGA CCC AGC GTA3' and reverse
5'CGC CGC CTG ACT ACG AGT AAC3'. The 244 bp prod-
uct was then digested with HpyCH4V. A T-allele was cut
into two fragments, of 174 bp and 70 bp, while a C-allele,
again, remained uncut. Genotyping was done by labora-
tory personnel blinded to case status, and a random 5% of
the samples were repeated to validate genotyping proce-
dures. Two authors independently reviewed the genotyp-
ing results, data entry, and statistical analyses.
Statistical analysis
For this case-control association study, we used standard
χ2 tests to determine the significance of differences in
allelic and genotypic frequencies between OA patients
and control subjects. P < 0.05 was considered statistically
significant. Allele and genotype proportions were tested
for Hardy-Weinberg equilibrium. Clinical variables age,
sex, BMI (body mass index) and K/L score of OA patients
with different genotype were compared using χ2 tests or
Kruskal-Wallis tests. Power estimates were calculated
using the software R.
Results
Table 1 shows the basic characteristics of the study popu-
lation. The patients and the controls were matched in age
and sex. Over 59% of the patients had a K/L score of 3 or
4. Table 2 shows the allele and genotype distributions for
cases and controls. Both of the allele and genotype pro-
portions were in Hardy-Weinberg equilibrium. The reces-
sive allele (T) and genotype (TT) frequencies of controls
(20.5% and 3.8%, respectively) were similar to those pre-
viously published in the Japan population [7] (P = 0.023
and 0.064) but not to those of UK Caucasians [11] (P =
0.000 and 0.000). In the association study, no significant
differences between cases and controls were observed
either in allele (P = 0.996) or genotype (P = 0.802) fre-
quencies, and the allele frequencies were even the same
between the two groups. Stratifying the samples by sex did
not result in any significant association (Table 2). Moreo-
ver, we did not find any association between the -16C/T
SNP genotype and the clinical variables age, sex, BMI and
K/L score in OA patients (Table 3 and Table 4). The power
for this study was over 0.05.
Discussion
Through a large-scale association study with subsequent
functional researches, the Japanese group have demon-
strated a convincing association between the CALM1 core
promoter polymorphism and Japanese hip OA. The well
clarified role Ca2+-calmodulin signal played in chondro-
genesis and normal cartilage phenotype maintaining,
together with the results of the microarray analysis [7]
showing higher levels of CALM1 expression both in hip
and knee OA, have interested us in assessing whether this
genetic polymorphism is also associated with OA in a Chi-
nese Han population. However, we failed to find any pos-
itive result. Before the present study, this potential
association had also been studied in UK Caucasian popu-
lations [11,12], yielding no positive findings either in hip
or knee OA patients. Together, these studies highlight the
complexity and diversity of genetic contributions to such
a multifactorial disease as OA.
The "T" allele and "TT" genotype frequencies of controls
in present study were very similar to those in the original
study of the Japan group but different to those in the UK
study [12]. The "T" allele even seemed to be the major
allele in UK Caucasians instead of the allele "C" which
was dominant in both the present and the Japanese stud-
ies, indicating a heterogenous nature of this polymor-
phism between Asians and UK Caucasians. The different
ethnic background and the potential linkage disequilib-
rium (LD) of the -16C/T locus with some other more rel-
evant allele or alleles within the CALM1 gene that differ in
different populations, may be one of the most likely
explanations for the failure to replicate the association of
-16C/T with OA susceptibility in UK Caucasians.
Recently, several population-based association studies for
other OA susceptibility genes have shown consistent
results in the Japanese and Chinese Han populations
[13,16]. Populations from neighboring regions may have
greater similarities in genome for the fact that they share
more recent common ancestors. Therefore, their allele fre-
quencies are more highly correlated, a pattern that is com-
monly manifested as a cline of allele frequencies [17]. All
these together had encouraged us to expect a positive asso-
ciation of -16C/T polymorphism in our population-based
study, except for the fact that there is an obvious differ-
Table 1: Subject characteristics
Subjects Number Sex Age (years) BMI K-L score
Female(%) Male Mean SD(±) Mean SD(±) =2 ≥ 3(%)
OA cases 183 124(67.8) 59 58.6 13.5 25.4 3.5 75 108(59)
Controls 210 142(67.6) 68 57.7 11.7 23.2 3.9
BMI: body mass index.BMC Medical Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2350/9/91
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ence in clinical phenotype of OA patients between the
present and the original Japanese studies -the different
joint site affected, which may account for the inconsistent
results of the two studies. It is becoming more apparent
that the nature of OA genetic susceptibility is likely to vary
between different joint sites [18]. In the RHOB and
TXNDC3 studies, different associations were detected for
the different affected joint sites [19-21]. A relatively small
population size might have prevented from seeing the
association. The proportion of genetic contribution of cer-
tain polymorphic locus to OA susceptibility may be influ-
enced by other local environmental factors such as
anatomical and biomechanical effects, and by some joint-
specific genetic factors most of which were postulated to
be involved in cell signalling and signal transduction
[18,22]. Interestingly, CALM1 is only one member of the
CALM family by which mammalian CaM is encoded. The
CALM  family includes three nonallelic genes CALM1,
CALM2  and  CALM3  located on chromosomes 14q24-
q31, 2p21.1-p21.3 and 19q13.2-q13.3, respectively, but
all these three genes encode an identical 148 amino acid
protein CaM [23]. However, the transcriptional activity
and the proportion of each gene contributing to the local
mRNA pools seem to differ during cell differentiation
processes or in different biochemical microenvironments
[24,25]. Thus, the other two CALM genes that are more
functionally active in the knee joint might have decreased
the extent to which the CALM1 OA risk is manifest. To
make our study more complete and comparable, it is nec-
essary to collect enough samples of hip OA despite of the
very much lower prevalence [26], and assess the associa-
tion between this polymorphism and hip OA in the same
Chinese population.
Moreover, Hoaglund [27] has recently made a comment
on the ascertainment criteria used for the patient enroll-
ment in the Japanese association study and has suggested
that the CALM1  core promoter polymorphism may be
associated with Japanese congenital hip disease causing
secondary hip OA rather than primary hip OA. Colleagues
in our department are now trying to identify this hypoth-
esis by assessing the association in patients of develop-
mental dysplasia of the hip (DDH) which may represent
a severe phenotype of congenital hip disease.
Conclusion
The present study did not find any significant association
between the CALM1 core promoter polymorphism (-16C/
T) and susceptibility to knee OA in the Chinese Han pop-
ulation. Further studies are necessary to identify the asso-
ciation of this polymorphism with hip OA in our
population and with OA in other different populations on
different joint sites to give a global view of this polymor-
phism in pathogenesis of OA.
Table 2: Association of SNP rs12885713 between OA cases and controls
Subjects Allele Genotype
C(%) T(%) P value CC(%) CT(%) TT(%) P value*
All cases (n = 183) 291(79.5) 75(20.5) 0.996 117(63.9) 57(31.1) 9(4.9) 0.802
All controls (n = 210) 334(79.5) 86(20.5) 132(62.9) 70(33.3) 8(3.8)
Female cases (n = 124) 198(79.8) 50(20.2) 0.818 79(63.7) 40(32.3) 5(4.0) 0.941
Female controls (n = 142) 229(80.6) 55(19.4) 93(65.5) 43(30.3) 6(4.2)
Male cases (n = 59) 93(78.8) 25(21.2) 0.758 38(64.4) 17(28.8) 4(6.8) 0.313
Male controls (n = 68) 105(77.2) 31(22.8) 39(57.4) 27(39.7) 2(2.9)
*Odds ratio and P value were calculated on recessive model (TT versus CT + CC).
Table 3: Clinical variables in the OA patients and the rs12885713 
genotype
Variable Genotype
CC CT TT P value
Mean SD Mean SD Mean SD
A g e 5 7 . 71 3 . 05 9 . 61 4 . 76 4 . 41 1 . 30 . 2 3 a
B M I 2 5 . 43 . 12 5 . 74 . 22 4 . 74 . 10 . 8 7 a
Sex (Male %) 32.5 29.8 44.4 0.68b
BMI: body mass index.
a The P values were calculated using Kruskal-Wallis test.
b The P values were calculated using χ2 test.
Table 4: Genotype distribution of OA subgroups stratified by K/L 
score
Genotype
K/L score Total CC(%) CT(%) TT(%) P value*
2 75 50(66.7) 21(28.0) 4(5.3) 0.86
3 54 37(68.5) 15(27.8) 2(3.7)
4 54 32(59.3) 19(35.2) 3(5.5)
* The P value was calculated using 3 × 3 χ2 test.BMC Medical Genetics 2008, 9:91 http://www.biomedcentral.com/1471-2350/9/91
Page 5 of 5
(page number not for citation purposes)
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
HN carried out the molecular genetic studies, performed
the statistical analysis and drafted the manuscript. JD, JQ,
YX, CY, LZ participated in sample collection and DNA
extraction. LY participated in the design of the study and
help to carry out the molecular genetic studies. QJ and DS
conceived of the study, and participated in its design and
coordination and helped to draft the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
This study was supported by the National Nature Science Foundation of 
China (30571874), Programme of Technology Development of Nanjing 
(200603001) and Scientific Research Foundation for Young Doctors of 
Drum Tower Hospital (2007).
References
1. Arden N, Nevitt MC: Osteoarthritis: epidemiology.  Best Pract
Res Clin Rheumatol 2006, 20:3-25.
2. MacGregor AJ, Antoniades L, Matson M, Andrew T, Spector TD: The
genetic contribution to radiographic hip osteoarthritis in
women: results of a classic twin study.  Arthritis Rheum 2000,
43:2410-2416.
3. Felson DT, Couropmitree NN, Chaisson CE, Hannan MT, Zhang Y,
McAlindon TE, LaValley M, Levy D, Myers RH: Evidence for a Men-
delian gene in a segregation analysis of generalized radio-
graphic osteoarthritis: the Framingham Study.  Arthritis Rheum
1998, 41:1064-1071.
4. Shi D, Nakamura T, Dai J, Yi L, Qin J, Chen D, Xu Z, Wang Y, Ikegawa
S, Jiang Q: Association of the aspartic acid-repeat polymor-
phism in the asporin gene with age at onset of knee osteoar-
thritis in Han Chinese population.  J Hum Genet 2007,
52:664-667.
5. Loughlin J: Genetic epidemiology of primary osteoarthritis.
Curr Opin Rheumatol 2001, 13:111-116.
6. Berridge MJ, Bootman MD, Lipp P: Calcium–a life and death sig-
nal.  Nature 1998, 395:645-648.
7. Mototani H, Mabuchi A, Saito S, Fujioka M, Iida A, Takatori Y, Kotani
A, Kubo T, Nakamura K, Sekine A, Murakami Y, Tsunoda T, Notoya
K, Nakamura Y, Ikegawa S: A functional single nucleotide poly-
morphism in the core promoter region of CALM1 is associ-
ated with hip osteoarthritis in Japanese.  Hum Mol Genet 2005,
14:1009-1017.
8. Valhmu WB, Stazzone EJ, Bachrach NM, Saed-Nejad F, Fischer SG,
Mow VC, Ratcliffe A: Load-controlled compression of articular
cartilage induces a transient stimulation of aggrecan gene
expression.  Arch Biochem Biophys 1998, 353:29-36.
9. Valhmu WB, Raia FJ: Myo-Inositol 1,4,5-trisphosphate and
Ca(2+)/calmodulin-dependent factors mediate transduction
of compression-induced signals in bovine articular chondro-
cytes.  Biochem J 2002, 361:689-696.
10. Piperno M, Reboul P, Hellio le Graverand MP, Peschard M, Annefeld
M, Richard M, Vignon E: Osteoarthritic cartilage fibrillation is
associated with a decrease in chondrocyte adhesion to
fibronectin.  Osteoarthritis Cartilage 1998, 6:393-399.
11. Loughlin J, Sinsheimer JS, Carr A, Chapman K: The CALM1 core
promoter polymorphism is not associated with hip osteoar-
thritis in a United Kingdom Caucasian population.  Osteoarthri-
tis Cartilage 2006, 14:295-298.
12. Valdes AM, Loughlin J, Oene MV, Chapman K, Surdulescu GL,
Doherty M, Spector TD: Sex and ethnic differences in the asso-
ciation of ASPN, CALM1, COL2A1, COMP, and FRZB with
genetic susceptibility to osteoarthritis of the knee.  Arthritis
Rheum 2007, 56:137-146.
13. Jiang Q, Shi D, Yi L, Ikegawa S, Wang Y, Nakamura T, Qiao D, Liu C,
Dai J: Replication of the association of the aspartic acid repeat
polymorphism in the asporin gene with knee-osteoarthritis
susceptibility in Han Chinese.  J Hum Genet 2006, 51:1068-1072.
14. Kellgren JH, Lawrence JS: Radiological assessment of osteoar-
throsis.  Ann Rheum Dis 1963, 22:237-255.
15. Walsh PS, Metzger DA, Higuchi R: Chelex 100 as a medium for
simple extraction of DNA for PCR-based typing from foren-
sic material.  Biotechniques 1991, 10:506-513.
16. Miyamoto Y, Mabuchi A, Shi D, Kubo T, Takatori Y, Saito S, Fujioka
M, Sudo A, Uchida A, Yamamoto S, Ozaki K, Takigawa M, Tanaka T,
Nakamura Y, Jiang Q, Ikegawa S: A functional polymorphism in
the 5' UTR of GDF5 is associated with susceptibility to oste-
oarthritis.  Nat Genet 2007, 39:529-533.
17. Bamshad M, Wooding S, Salisbury BA, Stephens JC: Deconstructing
the relationship between genetics and race.  Nat Rev Genet
2004, 5:598-609.
18. Peach CA, Carr AJ, Loughlin J: Recent advances in the genetic
investigation of osteoarthritis.  Trends Mol Med 2005,
11:186-191.
19. Loughlin J: Polymorphism in signal transduction is a major
route through which osteoarthritis susceptibility is acting.
Curr Opin Rheumatol 2005, 17:629-633.
20. Mahr S, Burmester GR, Hilke D, Göbel U, Grützkau A, Häupl T,
Hauschild M, Koczan D, Krenn V, Neidel J, Perka C, Radbruch A,
Thiesen HJ, Müller B: Cis- and trans-acting gene regulation is
associated with osteoarthritis.  Am J Hum Genet 2006,
78:793-803.
21. Loughlin J, Meulenbelt I, Min J, Mustafa Z, Sinsheimer JS, Carr A, Slag-
boom PE: Genetic association analysis of RHOB and TXNDC3
in osteoarthritis.  Am J Hum Genet 2007, 80:383-386.
22. Shi D, Nakamura T, Nakajima M, Dai J, Qin J, Ni H, Xu Y, Yao C, Wei
J, Liu B, Ikegawa S, Jiang Q: Association of single-nucleotide pol-
ymorphisms in RHOB and TXNDC3 with knee osteoarthri-
tis susceptibility: two case-control studies in East Asian
populations and a meta-analysis.  Arthritis Res Ther 2008 in press.
23. Berchtold MW, Egli R, Rhyner JA, Hameister H, Strehler EE: Locali-
zation of the human bona fide calmodulin genes CALM1,
CALM2, and CALM3 to chromosomes 14q24-q31, 2p21.1-
p21.3, and 19q13.2-q13.3.  Genomics 1993, 16:461-465.
24. Toutenhoofd SL, Strehler EE: Regulation of calmodulin mRNAs
in differentiating human IMR-32 neuroblastoma cells.  Biochim
Biophys Acta 2002, 1600:95-104.
25. Toutenhoofd SL, Foletti D, Wicki R, Rhyner JA, Garcia F, Tolon R,
Strehler EE: Characterization of the human CALM2 calmodu-
lin gene and comparison of the transcriptional activity of
CALM1, CALM2 and CALM3.  Cell Calcium 1998, 23:323-338.
26. Xu L, Nevitt MC, Zhang Y, Yu W, Alibadi P, Felson DT: High prev-
alence of knee, but not hip or hand osteoarthritis in Beijing
elders: comparison with data of Caucasian in United States.
Zhonghua Yi Xue Za Zhi 2003, 83:1206-1209.
27. Hoaglund FT: CALM1 promoter polymorphism gene and Jap-
anese congenital hip disease.  Osteoarthritis Cartilage 2007, 15:593.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/9/91/prepub